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EDITORIAL 
Chronic Fatigue Syndrome: The Need for an 
Integrative Approach 
The syndromal presentation of chronic f:~tigue, feverishness, diffuse pains and other 
constitutional complaints, often precipitated by an acute infectious illness and aggravated 
by physical and emotional stressors, has a len~hy history. It has been described in the 
medical literature since the early 1700',. Sir Richard Manningham wrote, in 1750, of 
the 'febricula' or 'little fever' which presented with a variety of constitutional complaints, 
but few objective clinical findings (Manningham 1750). One of the more lasting appel- 
lations for this cluster of symptoms, 'neurastbenia,' was introduced by George Beard in 
the late 19th century, and is still used ~oday in the 9th Revision of the World Health 
Organization's International Classification of Diseases (Beard 1869). Beard maintained 
that the etiology of this syndrome resided in subtle and undetectable alterations in neu- 
rochemistry, but the pathophysiology remains unknown more than a century later. Recent 
investigators have emphasized its heterogeneity, the multiple terms used to describe the 
syndrome, and its possible connections to other proposed entities such as fibromyalgia 
(Straus 1988a; Swartz 1988). The situation remains confusing. 
To facilitate identification of objective characteristics and improve comparability of 
research studies, the Centers for Disease Control recently proposed a working case def- 
inition, renaming the illness "chronic fatigue syndrome" (Holmes et al 1988). Essentially, 
patients meeting criteria for the syndrome must have persistent or relapsing, debilitating 
fatigue for at least six months in the absence of any apparent medical diagnosis which 
would explain the clinical presentation. The CDC symptom criteria for this syndrome are 
presented in Table 1. 
Two principal theories have dominated pathophysiologic concepts of this syndrome. 
One view has focused on the behavioral antecedents of the illness and maintains that this 
disorder represents the behavioral aftermath of an acute infectious event in psychologically 
susceptible individuals. In 1941, Paul Wood wrote, " . . .  patients should be informed of 
the nature of their illness and be treated as psychoneurotics; their distaste for this label 
may prove quite helpful . . .  The patient must be induced to believe that he is suffering 
from the effects of emotional disturbance and not from any disease or alteration of visceral 
func t ion . . . "  (Wood 1941). An alternate view has emphasized the importance of the 
infectious onset, with the protean constitutional symptoms emerging secondary to per- 
sistent irnm-me activation and/or other lasting pathophysiclogic changes caused by the 
initial infectious event. Inadequate attention has been given to how these two views might 
interface. 
A number of early studies served to bolster the 'behavioral' viewpoint noted above. 
In 1951, Spink studied 65 patients with docu_rnented acute brucella infection, and noted 
that approximately 20 per cent of these p~,tients proceeded to have prolonged symptoms 
without any objective evidence of continued active disease (Spink 195i). He observed a 
high degree of psychological morbidity in this subgroup of patients, and speculated that, 
" . . individuals with functional complaints or personality difficulties may have an ex- 
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Table 1. Centers for Disease Control (CDC) Case Criteria for Chronic Fatigue Syndrome 
Major Criteria: (Patient must fulfill major criteria ! and 2) 
I) New onset of persistent or relapsing, debilitating fatigue or easy fatigability that does not resolve 
with bedrest and is severe enough to impair average daily _activity below 50% of premorbid activity 
level, lasting for a period of at least 6 months. 
2) Exclusion of other clinical conditions or medication effects by appropriate history, physical 
examination or laboratory tests. 
Minor Critera: (Patient must show 6 or more of the symptom criteria and 2 or more of the physical criteria; 
or 8 or more of the symptom criteria) 
Symptom criteria (must have begun at or after onset of the fatigue and must be persistent or recurring): 
i) Mild fever or chills 
2) Sore throat 
3) Painful anterior or posterior cervical or axillary lymph nodes 
4) Generalized muscle weakness 
5) Myalgias 
6) Prolonged post-exertional fatigue 
7 x. Headaches 
8) Migratory arthralgia 
9) Neuropsychologic complaints (incl., photophobia, transient scotomata, forgetfulness, irritability, 
confusion, depression, poor concentration) 
10) Sleep disturbance 
11) Main symptom complex having an abrupt onset 
Physical criteria: (must be documented on at least two occasions, at least one month apart) 
1) Low grade fever (oral T 37.6-38.6°C or rectal T 37.8-38.8°C) 
2) Nonexudative pharyngitis 
3) Palpable anterior or posterior cervical or axillary lyi~;8~ aodes 
aggeration of these manifestations following acute brucellosis.. .  " Using mere for- 
malized psychological and medical assessments, Imboden and Cluff, at Johns Hopkins 
University, arrived at a similar .'gnclus~on (Imboden et al 1959). They summarized that 
chronic brucellosis, " . . .  consists mostly of an emotional disorder . . . .  "Reasoning that 
the factors involved in the delay of symptomatic recovery from acute brucellosis might 
be applicable to other acute infections, Imboden and Cluff designed a prospective psy- 
chological evaluation of 600 individuals prior to the onset of the expected nationwide 
epidemic oi Asian influenza in i957 (imboden 1961). Twenty-six individuals developed 
the influenza syndrome; 12 had symptoms that persisted beyond three weeks. Their 
prospective evaluation confirmed that patients in the persistently ill group showed uni- 
formly higher levels of pre-illness psychological distress. Recently published studies using 
structured psychiatric interview techniques have also suggested that the prevalence of 
psychiatric illness was higher in patients with chronic fatigue syndrome than in the general 
population, and often preceded the onset of the fatigue syndrome (Taerk et al 1987; Manu 
et ai 1988; Mar~u et al 1989; Kruesi et al 1989; Gold et al 1990). Only one study reported 
the prevalence of psychiatric illness to be comparable to that of the general population, 
and to follow, rather than precede the development of the chronic fatigue (Hickie et al 
1990). However, lacking reliable biological measures to identify this syndrome, and given 
that most established psychiatric diagnostic systems include fatigue as a symptom of 
psychiatric disorder, the use of phenomenologic criteria alone introduces an unavoidable 
circularity of reasoning when trying to establish a definitive distinction between chronic 
fatigue and a psychiatric illness. 
Editorial BIOL PSYCHIATRY 749 
1991 ;30:747-752 
Evidence supporting an infectious or persistent immune dysregulation hypothesis for 
the pathophysiology of chronic fatigue has largely emerged from a series of reports which 
began appearing between 982 and 1985. These studies reported a spectrum of subtle 
abnormalities in cell-mediated and humoral immunity in these patients, along with atypical 
profiles of antibody responses to the Epstein-Barr virus and other viral antigens (Tobi et 
al 1982; Jones et al 1985; Straus et al 1985). These immunologic disturbances, coupled 
with the clinical observation that many of these patients developed the syndrome following 
an episode of acute infectious mononucleosis, led to the specific hypothesis that the illness 
was a manifestation of chronic Epstein-Barr virus infection. However, several subsequent 
observations challenge this idea and suggest that, while immune activation may be present 
in these patients, persistent Epstein-Barr virus infection is almost certainly not a tenable 
explanation for most cases of the syndrome. First, the magnitude or pattern 9f the antibody 
titers bears no relationship to the severity of the clinical presentation. Furthermore, 
controlled studies of seroepidemiology showed that enhanced activity of the Epstein-Barr 
virus may persist for as long as 30-104 months after the acute infection in otherwise 
asymptomatic individuals (Horwitz et al 1985; Holmes et al !987; Buchwald et al 1987). 
Finally, a controlled trial of intravenous and oral acyclovir was without effect in patients 
with chronic fatigue syndrome (Straus et al 1988b). Nevertheless, a role for persistent 
pathophysiologic changes following an acute viral infection, has n~t been excluded as a 
possible pathogenesis of chronic fatigue syndrome. Indeed, Oldstone and colleagues, 
have provided evidence in animals demonstrating that viral infections may lead to long- 
lasting pathologic changes in differentiated cellular f,nctions, long after the infection 
itself has resolved (Oldstone et al 1982). This process may result in substantial disturbances 
in organismic homeostasis, without damaging the morphologic appearance of the infected 
cells. 
Despite the prominence of central nervous system symptoms in these patients, re- 
markably few studies of this syndrome have involved investigators skilled in psychiatry. 
The lack of such involvement has consistently impaired an integrative understanding of 
this syndrome, limited the development of new pathophysiologic models, perpetuated the 
stigma associated with behavioral symptoms, and foster,=d methodologic problems in 
research. At the present time, a scientific bias in research in this area persists in the form 
of a search for a specific, infection-produced disturbance in immune function. This is 
the case despite the fact that there exists little evidence to suggest that the observed mild 
immune ~h,,,,,~n,;,~ ~r,~ ,~f any functiona I ~igpific'ane~ P~vehiatrically ill comparison 
IML ILJ I i l LF I  i l l L ~ l l l ,  l q ~ e d  ~ q ~  q . . J l  1 & l  s ~ m/ . . . . . . . .  
groups have been virtually absent, with one important exception (Wessely, Powell 1989). 
In their study, Wessely and Powell conclude that the description of fatigue in patients 
with "postviral" fatigue syndrome more closely resembled a comparison group of affec- 
tively ill patients than a group of patients with primary neuromuscular disorders. However, 
they emphasize that depression alone cannot be the sole explanation for the similarity in 
phenomenologic presentation. Nearly one third of all patients with "postviral" fatigue 
had no diagnosable psychiatric disorder. In their words, "[chronic fatigue syndrome] is 
a heterogenous condition, depressive illness is a sufficient, but not necessary, explana- 
tion . . . .  " 
An interdisciplinary approach to studies in this area is advocated; psychiatry should 
be a primary component of such an approach. It is ironic that most non-psychiatric 
researchers in this field have long acknowledged the need for such involvement. For 
instance, a formal structured psychiatric interview ;s now considered to be an essential 
component of a credible research workup for chronic fatigue syndrome. These issues 
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were discussed in detail at a recent workshop on the Definition and Medical Outcome 
Assessment of Chronic Fatigue Syndrome in Research, sponsored jointly by the National 
Institute of Mental Health and the National Institute for Allergy and Infectious Diseases. 
This commendable joint effort represented the first formal involvement of the NIMH in 
this area. 
To begin exploring potential biological underpinnings of the clinical common ground 
between chronic fatigue syndrome and primary psychiatric illness, we recently advanced 
data suggesting that the phenomenologic overlap may reflect the occurrence of a shared, 
final common biological pathway that may be precipitated by a variety of infectious or 
non-infectious pathophysiologic antecedents (Demitrack et al 1991). Several lines of 
evidence implicate disturbances in the hypothalamic-pituitary-adrenal axis as this shared 
final pathway. First, a review of the clinical presentation of chronic fatigue syndrome 
shows considerable overlap with that seen in patients with giucocorticoid deficiency 
(Baxter et al 1981). Indeed, one of the principal symptoms of glucocorticoid deficiency 
is debilitating fatigue. An abrupt onset precipitated by a stressor, feverishness, arthralgias, 
myalgias, adenopathy, postexertionai fatigue, exacerbation of allergic responses, and 
disturbances in mood and sleep are also characteristic of glucocorticoid insufficiency. 
Notably, these symptoms are often seen in the relatively rare syndrome of partial or sub- 
clinical adrenal insufficiency, which may only be detectable by ACTH stimulation or 
other endocrine testing in patients who fail to show the symptoms of classical Addison's 
disease, such as hypotension and abnormal fluid and electrolyte balance. Since gluco- 
corticoids represent the most potent endogenous irrmmnosuppressive agents, we further 
suggest that many of the observed immunologic disturbances i~l patients with chronic 
fatigue syndrome (e.g., exacerbation of allergic responses, and the profile of enhanced 
antibody titers to a variety of viral antigens) could also reflect a mild glucocorticoid 
deficiency. In this regard, it has recently been shown in animals that a defect in the 
responsiveness of the hypothalamic-pituitary-adrenal axis to immune mediators confers 
a risk for the development of inflammatory disease (Steinberg et al 1989a; Sternberg et 
al 1989b). 
A second line of evidence implicating disturbances in the functional integrity of the 
hypothalamic-pituitary-adrenal axis focuses upon corticotrop~n-releasing hormone. Other 
clinical populations with similar behavioral features characterized by profound lethargy, 
fatigue and depressed mood (ofie~ :eferred to ae 'atypical' depressive syndromes), may 
show evidence of hypofunctioning of hypotha!amic co rticotropin-releasing hormone neu- 
rons. These illnesses include Cushing's disease (Kling et al 1991; Tomori et al 1983), 
hypothyroidism (Kamilaris et al 1987), and the depressed phase of seasonal affective 
disorder (Joseph-Vanderpool et al 1991). These findings are of interest because corti- 
cotropin-releasing ho~one  serves not only as the principal stimulus to the pituitary- 
adrenal axis, and hence could be involved in cases of subtle adrenal insufficiency, but 
also because it is a behaviorally-active c~eurohormone whose central administration to 
animals and non-human primates induces signs of physiological and behavioral arousal, 
including activation of the sympathetic nervous system (Brown et al 1982), hyperre- 
sponsiveness to sensory stimuli (Swerdlow et al 1986), and increased locomotion (Sutton 
et al 1982). Hence, a functional deficit of hypothalamic corticotropin-releasing b 9rmone 
could contribute to the profound lethargy and fatigue that are inherent characteristics of 
both 'atypical' depressive syndromes and chronic fatigue syndrome, either through direct 
effects upon the central nervous system or indirectly by causing glucocorticoid deficiency. 
In summary, we have hypothesized that a variety of infectious or non-infectious patho- 
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physiologic antecedents may lead to a specific neuroendocrine deficit, namely, a reduction 
in adrenal glucocoriicoid secretion mediated by an impairment in the central nervous 
system regulation of the axis. This pattern of secondary a&en-,d insufficiency, in ram, 
may be a consequence of as well as a causative factor in the development of many of 
the behavioral and biochemical abnormalities that have been described in patients with 
chronic fatigue syndrome. Similarly, other clinical states, with widely differing patho- 
physiologies, may result in a fatigue-like syndrome due to a functional deficit in hypo- 
thalamic corficotropin-releasing hormone. 
The validity of this model remains to be determined. Of greatest importance, available 
data indicate that as investigators evaluate this model, or any other, an integrated, in- 
terdisciplinary perspective is crucial. Characteristics essential to such an approach include 
thorough psychiatric assessments using standardized instruments with demonstrated re- 
liability and --':":'-'v ,u,,~tt~, ,.,-,.,,eL.,,,,..,,""-'"""";"° ------.,~"~h'c'~'-~" ,~mrdnvin,,r.v., ...~, rle~rly_ . . . . . . . .  defined psychiatric popu- 
lations, and neurobiological models which address the interaction of brain and behavior 
in the clinical expression of this illness. 
Mark A. Demitrack 
Department of  Psychiatry 
University of  Michigan Medical Center 
1500 East Medical Center Drive 
Ann Arbor, Michigan 48109--0116 
John F. Greden 
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